Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Oak HC/FT active in biotech investment

Since its founding in 2014, Oak HC/FT has invested in firms in health care and financial technology. A 2020 defined by the coronavirus pandemic did...

| By Kelley Gipson

SCSU hosts Virtual Bioscience Careers Forum 4/30

Companies, faculty, and students are invited to register for the Virtual Bioscience Careers Forum at Southern Connecticut State University April 30.  The theme is “Technology,...

| By Kelley Gipson

Hyperfine, Wellinks report new appointments

Hyperfine Research of Guilford reports that Dr. Khalil Salman has joined the company as its new director of clinical informatics … more New Haven startup Wellinks...

| By Kelley Gipson

Pfizer site leader cites Groton COVID-19 work

The site leader at the Pfizer labs in Groton says about 200 colleagues locally have been so focused on developing a vaccine to battle COVID-19, it’s...

| By Kelley Gipson

Top companies’ include IsoPlexis, Hyperfine, Sema4′

The 2020 Fierce 15 list of companies includes Connecticut’s IsoPlexis and Hyperfine. The Forbes list of “America’s Best Startup Employers” includes Connecticut’s Sema4 … more

| By Kelley Gipson

Artizan and Cybrexa complete financing rounds

Yale spinout Artizan Biosciences, a New Haven biotech focused on curing inflammatory bowel disease, has raised $11 million in a financing round that includes an...

| By Kelley Gipson

Nanoviricides reports progress on anti-COVID drugs

Nanoviricides reports that its two COVID-19 drug candidates have been “highly effective” against the virus in pre-clinical laboratory studies. The Shelton-based company is preparing a pre-IND...